Impact of Adherence on Treatment Outcomes in Diabetic Patients


Diabetes mellitus is still a burden in Indonesia. Failure of treatment may cause the worsening of this disease. This study aimed to define the association between patient adherence and treatment outcomes. We used a cross-sectional design with data from a public hospital in Java. We collected the patients’ characteristics, medical treatments and treatment outcomes from their medical records. The inclusion criteria were adult diabetes mellitus patients without any comorbidities or complications and using antidiabetic medicine (oral and/or injection). The patients’ adherence was assessed using the MARS questionnaire. We recruited 167 subjects from the hospital. Most of the subjects were male (60.0%), the average age was 60.47 (SD: 10.80), 43.7% had single treatment and 50.3% did not adhere. 58.7% subjects had uncontrolled fasting blood glucose (FBG) and 86.6% subjects had uncontrolled HbA1C. After adjusting for subjects’ characteristics, there was a significant association between FBG and adherence. Adherence may increase FBG by as much as 1.95 times (95% CI: 1.04- 3.65). We also found a significant association between adherence and the treatment outcome. Thus, we recommend that health care for diabetes mellitus patients must be complemented with education to increase adherence and improve outcomes.

Keywords: diabetes, adherence, treatment outcomes

[1] IDF. IDF diabetes atlas. 7th ed. 2015.

[2] M. of I. Health. Indonesia Health Profile.2019.

[3] Nassar CM, Montero A, Magee MF. Inpatient diabetes education in the real world: An overview of guidelines and delivery models. Curr Diab Rep. 2019 Sep;19(10):103.

[4] Shawahna R, Samaro S, Ahmad Z. Knowledge, attitude, and practice of patients with type 2 diabetes mellitus with regard to their disease: A cross-sectional study among Palestinians of the West Bank. BMC Public Health. 2021 Mar;21(1):472.

[5] Tan JP, Cheng KK, Siah RC. A systematic review and meta-analysis on the effectiveness of education on medication adherence for patients with hypertension, hyperlipidaemia and diabetes. J Adv Nurs. 2019 Nov;75(11):2478–94.

[6] Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res. 2013 Jun;11(2):54–65.

[7] Shaha KC, Sultana S, Saha SK, Shahidullah SM, Jyoti BK. Patient characteristics associated with medication adherence to anti-diabetic drugs. Mymensingh Med J. 2019 Apr;28(2):423–8.

[8] Shams N, Amjad S, Kumar N, Ahmed W, Saleem F. Drug non-adherence in type 2 diabetes mellitus; predictors and associations. J Ayub Med Coll Abbottabad. 2016 Apr-Jun;28(2):302–7.

[9] McGovern A, Tippu Z, Hinton W, Munro N, Whyte M, de Lusignan S. Comparison ofmedication adherence and persistence in type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab. 2018 Apr;20(4):1040–3.

[10] Shiomi M, Kurobuchi M, Tanaka Y, Takada T, Otori K. Pill counting in the determination of factors affecting medication adherence in patients with type 2 diabetes: A retrospective observational study. Diabetes Ther. 2021 Jul;12(7):1993– 2005.

[11] Habib B, Buckeridge D, Bustillo M, Marquez SN, Thakur M, Tran T, et al. Smart About Meds (SAM): A pilot randomized controlled trial of a mobile application to improve medication adherence following hospital discharge. JAMIA Open. 2021 Jul;4(3):ab

[12] Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. Impact of Health chronic disease management on treatment adherence and patient outcomes: A systematic review. J Med Internet Res. 2015 Feb;17(2):52.

[13] Selvadurai S, Cheah KY, Ching MW, et al. Impact of pharmacist insulin injection re-education on glycemic control among type II diabetic patients in primary health clinics. Saudi pharmaceutical Journal: SPJ: the official publication of the Saudi Pharmaceutical Society. 2021;29(7):670-

[14] Viana LV, Gomes MB, Zajdenverg L, Pavin EJ, Azevedo MJ; Brazilian Type 1 Diabetes Study Group. Interventions to improve patients’ compliance with therapies aimed at lowering glycated hemoglobin (HbA1c) in type 1 diabetes: Systematic review and meta-analyses of randomized controlled clinical trials of psychological, telecare, and educational interventions. Trials. 2016 Feb;17(1):94.

[15] Doggrell SA, Warot S. The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. Int J Clin Pharm. 2014 Jun;36(3):488–97.

[16] Patel S, Abreu M, Tumyan A, Adams-Huet B, Li X, Lingvay I. Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study. BMJ Open Diabetes Res Care. 2019 Nov;7(1):000761.